Manager TitleAgeSince
Chief Executive Officer 61 -
Director of Finance/CFO 47 01/09/2023
Chief Tech/Sci/R&D Officer - 01/09/2021
Director TitleAgeSince
Director/Board Member 47 01/09/2023
Director/Board Member 61 -
Date Insider Type Main position Quantity % Market Cap.
01/09/23 Issuer sale

Director

12,343 0.0235%
01/09/23 Issuer sale

Chairman

32,034 0.0611%
01/09/23 Issuer sale

Director

18,338 0.0350%
Change 5-day change 1-year change 3-year change Capi.($)
-2.24%+1.48% - - 208.49Cr
+0.43%+2.14%-19.78%-11.93% 18TCr
+0.34%-1.72%-10.75%-7.48% 10TCr
+1.04%-1.44%+3.45%+58.56% 5.85TCr
-0.82%-1.93%+38.23%+58.17% 5.14TCr
-0.01%-4.24%-16.12%-45.30% 4.22TCr
+1.20%-8.32% - - 3.14TCr
-1.06%-9.52%-18.36%-44.75% 2.76TCr
-0.64%-0.83%+58.12%-4.42% 2.53TCr
+0.08%-4.72%-6.56%-9.25% 2.05TCr
Average -0.16%+0.60%+3.53%-0.80% 5.97TCr
Weighted average by Cap. +0.23%+3.97%-4.50%+0.18%
Logo NuVasive, Inc.
NuVasive, Inc. is a medical technology company. The Company is focused on developing, manufacturing, selling and providing procedural solutions for spine surgery, with a guiding purpose to transform surgery, advance care and change lives. It offers a portfolio of procedurally integrated spine surgery solutions, including surgical access instruments, spinal implants, fixation systems, biologics, and enabling technologies, as well as systems and services for intraoperative neuromonitoring. In addition, it develops and sells magnetically adjustable implant systems for the spine and specialized orthopedic procedures. It also designs and sell expandable growing rod implant systems for the treatment of early-onset scoliosis that can be non-invasively lengthened after implantation with incremental adjustments via an external remote controller using magnetic technology called MAGneticExternal Control (MAGEC). It operates in more than 50 countries serving surgeons, hospitals, and patients.
Employees
3,000
  1. Stock Market
  2. Stocks
  3. NUVA Stock